-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Maintains Neutral on AbbVie, Raises Price Target to $260

Benzinga·07/15/2026 15:18:37
Listen to the news
Citigroup analyst Geoff Meacham maintains AbbVie (NYSE:ABBV) with a Neutral and raises the price target from $230 to $260.